Infectious diseases pose a significant threat to global health. Early detection and accurate diagnosis are crucial for containing outbreaks, guiding treatment decisions, and preventing transmission. Clinical diagnostic testing plays a vital role in managing infectious diseases effectively by identifying causative agents such as bacteria, viruses, parasites, or fungi.
Timely and accurate diagnostic testing not only improves patient outcomes but also informs public health initiatives and targeted interventions. This necessity becomes more apparent during outbreaks or pandemics, like COVID-19, when rapid testing is essential for identifying cases, implementing containment measures, and allocating resources. Diagnostic testing provides reliable data for evidence-based decision-making, crucial for mitigating the impact of infectious diseases on individuals and communities.
This COVID-19 Antigen Test Kit (FDA EUA Approved) is a rapid, accurate, and reliable test for the detection of SARS-CoV-2, the virus that causes COVID-19. This test is designed to detect the presence of the virus in the upper respiratory tract and is intended for use in individuals who are suspected of having an active COVID-19 infection.
The test is easy to use and provides results in as little as 15 minutes. The test kit includes a nasal swab, a sample collection tube, and a test cassette. The nasal swab is used to collect a sample from the upper respiratory tract, which is then placed into the sample collection tube. The sample is then added to the test cassette, which contains a reagent that reacts with the virus if it is present. The results are then read from the test cassette, with a positive result indicating the presence of the virus.
The COVID-19 Antigen Test Kit (FDA EUA Approved) is highly accurate, with a sensitivity of 97.2% and a specificity of 99.6%. It is also easy to use, with minimal training required. The test is also cost-effective, making it an ideal choice for screening large numbers of people. Overall, the COVID-19 Antigen Test Kit (FDA EUA Approved) is an accurate, reliable, and cost-effective way to detect the presence of SARS-CoV-2 in individuals who are suspected of having an active COVID-19 infection.
FDA EUA Approved (No. EUA240006)
This test is authorized for the qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B protein antigens. This test is authorized for non-prescription home use with self-collected anterior nasal swab specimens from individuals aged 14 years or older, or with adult-collected anterior nasal swab specimens from individuals two (2) years or older.
Stay ahead of the curve and ensure your health with our latest Tyfast Flu A/B & COVID-19 Multiplex Rapid Home Test Kit (OTC options). This state-of-the-art rapid test empowers you to quickly check for both flu (A & B) and COVID-19 infection from the comfort of your home in just 10 minutes. Perfect for anyone experiencing symptoms of respiratory diseases, our kit offers peace of mind with swift and accurate results.
INTENDED USE
Monkeypox Virus Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of monkeypox virus antigen in human rash exudates and blood samples.
MATERIALS PROVIDED
• Monkeypox Virus Ag Test
• Instructions Sheet
• Pipette
• Swab
• Treatment tube containing sample treatment solution
• Buffer solution
INTENDED USE
Monkeypox Virus IgM/IgG Ab Test is a lateral flow chromatographic immunoassay used for the qualitative detection of monkeypox virus IgM and IgG antibodies in human whole blood/serum/plasma samples.
MATERIALS PROVIDED
• Monkeypox Virus IgM/IgG Test
• Instructions Sheet
• Buffer solution
• Pipette
• Alcohol cotton
• Sterilized lancet
INTENDED USE
Monkeypox Virus IgM/IgG Ab Test is a lateral flow chromatographic immunoassay used for the qualitative detection of monkeypox virus IgM and IgG antibodies in human whole blood/serum/plasma samples.
MATERIALS PROVIDED
• Monkeypox Virus IgM/IgG Test
• Instructions Sheet
• Buffer solution
• Pipette
• Alcohol cotton
• Sterilized lancet
INTENDED USE:
The saliva collection system is designed for self-contained saliva sample collection which provides critical sample consistency while amplifying, preserving, and protecting transcripts at the point of collection for highly sensitive and highly specific analysis. Sample self-collection using a saliva collection kit provides 100% in-device live viral neutralization in 10 seconds at room temperature, mitigating any risk of exposure for downstream processes. The saliva kits have no special storage or transport temperature-control requirements for collected saliva samples and eliminate the need for UN3373 biohazard shipping designation with clearance from USPS, FedEx, & UPS.
FEATURES: